Breath-hold Cardiac Hybrid SPECT/CCTA
Usefulness of Breath-hold Triggered SPECT-MPI in Cardiac Hybrid SPECT/CCTA Imaging
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims at combining inspiration breath-hold myocardial perfusion SPECT with coronary CT angiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started May 2015
Shorter than P25 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 13, 2015
CompletedFirst Posted
Study publicly available on registry
June 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedMay 11, 2016
May 1, 2016
1 year
May 13, 2015
May 10, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Image quality as visually assessed on a Likert scale
1 day
Number of image artefacts
1 day
Study Arms (1)
Breathhold SPECT-MPI vs. standard freebreathing SPECT-MPI
OTHERInterventions
Respiratory triggered SPECT myocardial perfusion imaging
Clinically indicated, standard non-respiratory triggered SPECT myocardial perfusion imaging
Clinically indicated coronary CT angiography serving as standard of reference
Eligibility Criteria
You may qualify if:
- Referral for cardiac hybrid SPECT/CCTA
- Male and female subjects 18 years of age or older
- Written informed consent by the participant after information about the project
You may not qualify if:
- Contraindications for coronary CT angiography (including renal failure with a GFR \<30ml/min/1.73m2, allergies to iodinated contrast agents)
- Pregnancy or breast-feeding
- Previous coronary revascularisation
- Inability to follow the examination procedure (e.g. due to language barriers, severe mental disease etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nuclear Medicine, University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2015
First Posted
June 11, 2015
Study Start
May 1, 2015
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
May 11, 2016
Record last verified: 2016-05